These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 33291304)

  • 21. Neuro-Immunity and Gut Dysbiosis Drive Parkinson's Disease-Induced Pain.
    Roversi K; Callai-Silva N; Roversi K; Griffith M; Boutopoulos C; Prediger RD; Talbot S
    Front Immunol; 2021; 12():759679. PubMed ID: 34868000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harnessing the immune system for the treatment of Parkinson's disease.
    Vedam-Mai V
    Brain Res; 2021 May; 1758():147308. PubMed ID: 33524380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
    Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H
    Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory Bowel Diseases and Parkinson's Disease.
    Brudek T
    J Parkinsons Dis; 2019; 9(s2):S331-S344. PubMed ID: 31609699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotics for Parkinson's Disease.
    Gazerani P
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Appendix in Parkinson's Disease: From Vestigial Remnant to Vital Organ?
    Killinger B; Labrie V
    J Parkinsons Dis; 2019; 9(s2):S345-S358. PubMed ID: 31609697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases.
    Gerhardt S; Mohajeri MH
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29857583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral aetiopathogenic drivers and mediators of Parkinson's disease and co-morbidities: role of gastrointestinal microbiota.
    Dobbs SM; Dobbs RJ; Weller C; Charlett A; Augustin A; Taylor D; Ibrahim MA; Bjarnason I
    J Neurovirol; 2016 Feb; 22(1):22-32. PubMed ID: 26092111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain Autoimmunity and Intestinal Microbiota: 100 Trillion Game Changers.
    Wekerle H
    Trends Immunol; 2017 Jul; 38(7):483-497. PubMed ID: 28601415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurodegeneration and Neuroinflammation in Parkinson's Disease: a Self-Sustained Loop.
    Arena G; Sharma K; Agyeah G; Krüger R; Grünewald A; Fitzgerald JC
    Curr Neurol Neurosci Rep; 2022 Aug; 22(8):427-440. PubMed ID: 35674870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases.
    Sommer A; Winner B; Prots I
    Mol Neurodegener; 2017 Oct; 12(1):78. PubMed ID: 29078813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson's disease.
    Jones JD; Rahmani E; Garcia E; Jacobs JP
    Parkinsonism Relat Disord; 2020 Mar; 72():7-12. PubMed ID: 32058266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Parkinson's disease have an immunological basis? The evidence and its therapeutic implications.
    Fiszer U
    BioDrugs; 2001; 15(6):351-5. PubMed ID: 11520246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Gut and Parkinson's Disease: Hype or Hope?
    Scheperjans F; Derkinderen P; Borghammer P
    J Parkinsons Dis; 2018; 8(s1):S31-S39. PubMed ID: 30584161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson's Disease: A Systematic Review.
    Boertien JM; Pereira PAB; Aho VTE; Scheperjans F
    J Parkinsons Dis; 2019; 9(s2):S297-S312. PubMed ID: 31498131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A role of the gastrointestinal tract microbiota in the pathogenesis of Parkinson's disease].
    Alifirova VM; Zhukova NG; Zhukova IA; Latypova AV; Titova MA; Mironova YS; Izhboldina OP; Nikitina MA; Petrov VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):174-179. PubMed ID: 28635757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson's Disease.
    McGee DJ; Lu XH; Disbrow EA
    J Parkinsons Dis; 2018; 8(3):367-374. PubMed ID: 29966206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linking Smoking, Coffee, Urate, and Parkinson's Disease - A Role for Gut Microbiota?
    Scheperjans F; Pekkonen E; Kaakkola S; Auvinen P
    J Parkinsons Dis; 2015; 5(2):255-62. PubMed ID: 25882059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.